Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The United States heart valve devices market was valued at USD 3.93 Billion in 2025, driven by the advancements in medical technology, an expanding aging population, and increasing prevalence of cardiovascular diseases in the region. The market is anticipated to grow at a CAGR of 9.60% during the forecast period of 2026-2035, with the values likely to reach USD 9.83 Billion by 2035.
Q1 2026 Market Updates
The US-Israel-Iran conflict, which escalated on 28 February 2026, is posing significant supply chain challenges for the United States heart valve devices market. Heart valve devices - both mechanical and bioprosthetic - rely on specialised materials including titanium, cobalt-chromium alloys, and bovine or porcine pericardial tissue processed under strict cold-chain conditions. The closure of the Strait of Hormuz has disrupted approximately 20% of global seaborne trade, while Gulf region air-cargo capacity dropped 79% in the first days of the conflict, directly affecting the movement of these critical materials.
Mechanical heart valves are manufactured using titanium and cobalt-chromium alloys valued for their biocompatibility, corrosion resistance, and durability. The Strait of Hormuz blockade has disrupted titanium supply routes from key exporters including Switzerland and Israel, driving up prices. Medical device manufacturers have reported raw material cost increases of 40–60%, with finished device prices rising 5–25%. Bioprosthetic valves, which use bovine pericardium leaflets secured by cobalt-chromium alloy stents, face dual pressure from rising metal costs and cold-chain logistics disruptions threatening the integrity of biological tissue components.
The Iran-linked cyberattack on Stryker has heightened concerns across the broader surgical device ecosystem. While Stryker is primarily associated with orthopaedic and neurosurgical instruments, the attack has underscored the vulnerability of medical device IT infrastructure to state-sponsored cyber threats. US bank and healthcare regulators have issued heightened cybersecurity advisories to all medical device firms, including cardiovascular device manufacturers, urging strengthened defences against wiper malware and denial-of-service attacks.
Procurement teams at US hospitals and cardiac surgery centres are responding by extending safety stock levels for heart valve devices, renegotiating supplier contracts with diversification requirements, and qualifying alternative vendors to reduce single-source dependency on components transiting through conflict-affected corridors.
Key Takeaways
Government: US healthcare regulators have issued heightened cybersecurity advisories to medical device manufacturers following the Iran-linked cyberattack on Stryker, urging the cardiovascular device sector to bolster IT defences. Government agencies are evaluating strategic stockpiling measures for critical cardiac surgical devices to reduce vulnerability to geopolitical supply disruptions. Regulatory bodies are under pressure to streamline alternative device approval pathways to address potential shortages of heart valve components.
Market: Raw material costs for heart valve device manufacturers have risen 40–60%, with titanium and cobalt-chromium alloy prices climbing due to disrupted supply routes through the Strait of Hormuz. Bioprosthetic valve producers face compounded risks from both rising metal costs and cold-chain logistics disruptions threatening biological tissue component integrity. Finished heart valve device prices have increased 5–25%, with further escalation expected if the conflict persists into Q2 2026.
Procurement: Lead times for titanium and cobalt-chromium alloy components used in heart valve manufacturing have extended as shipments reroute away from Gulf transit corridors. US hospitals and cardiac surgery centres are building buffer inventories and qualifying alternative suppliers to maintain uninterrupted access to heart valve devices. Procurement costs for cold-chain logistics have risen sharply due to air freight disruptions, increasing landed costs for temperature-sensitive bioprosthetic valve components.
2025
Base Year
2019-2025
Historical Period
2026-2035
Forecast Period
-
The rising prevalence of cardiovascular diseases is fueling the demand for effective treatments, including heart valve replacements and repairs, which is likely to boost market growth.
-
Major market players are securing significant funding to develop innovative solutions, such as robotic delivery platforms and next-generation valve technologies, which is projected to elevate the United States heart valve devices market value in the forecast period.
-
The rising adoption of minimally invasive technologies and the increasing regulatory approvals of advanced heart valve devices are some of the major market trends.
Compound Annual Growth Rate
9.6%
Value in USD Billion
2026-2035
*this image is indicative*
United States Heart Valve Devices Market Overview
Heart valve devices refer to medical devices designed to repair or replace damaged or diseased heart valves. These devices are used for the treatment of conditions such as aortic stenosis, mitral regurgitation, and tricuspid regurgitation. The rising advancements in technology, increasing prevalence of cardiovascular diseases, and favorable regulatory environments are some of the major drivers of the United States market for heart valve devices. Moreover, the country benefits from favorable regulatory frameworks and reimbursement policies that encourage the adoption of advanced heart valve devices, which is likely to fuel the market growth in the forecast period.
United States Heart Valve Devices Market Growth Drivers
Rising Prevalence of Cardiovascular Diseases to Support Market Growth
Cardiovascular diseases (CVDs), including heart disease, stroke, and heart valve diseases, are becoming increasingly prevalent due to lifestyle factors such as poor diet, lack of exercise, smoking, and excessive alcohol consumption. In 2022, coronary heart disease (CHD) accounted for 39.5% of all deaths attributable to cardiovascular diseases in the United States, followed by stroke at 17.6%, and other CVD at 17%, according to the American Heart Association. The growing prevalence of these conditions is driving the demand for heart valve devices to treat and manage valve-related diseases, which is anticipated to support market expansion in the country in the coming years.
United States Heart Valve Devices Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
United States Heart Valve Devices Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Valve Type
- Biological (Tissue) Valve
- Mechanical Valve
Market Breakup by Product Type
- Replacement Devices
- Mechanical Valve
- Bioprosthetic Valve
- Transcatheter Aortic Valve Replacement (TAVR)
- Repair Devices
- Surgical Valve
- Transcatheter Mitral Valve Replacement (TMVR)
- Balloon Valvuloplasty Devices
Market Breakup by Procedure
- Open Surgery
- Minimally Invasive Surgery (MIS)
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Others
United States Heart Valve Devices Market Share
Segmentation Based on Valve Type to Witness Substantial Growth
Based on the valve type, the market is segmented into biological (tissue) valve and mechanical valve. In the United States, the biological (tissue) valve segment covers a substantial market share, which is primarily due to the valves' natural composition that reduces the need for long-term anticoagulation therapy compared to mechanical valves. Moreover, advancements in tissue engineering and preservation are improving the durability and performance of biological valves, thereby boosting their market demand.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
United States Heart Valve Devices Market Analysis by Region
In the United States, the Northeast and West Coast regions hold a high market value due to advanced healthcare infrastructure and higher adoption rates of innovative treatments like transcatheter aortic valve replacement (TAVR). The Midwest and Southern states are witnessing a growing demand, owing to the expanding aging population and increasing prevalence of cardiovascular diseases, which are fueling the need for heart valve treatments. Moreover, the presence of major medical device companies and healthcare hubs in states like California, Massachusetts, and Minnesota is expected to boost market growth in the region.
Leading Players in the United States Heart Valve Devices Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Medtronic plc
Medtronic is a leading player in the heart valve devices market of the United States, with its TAVR systems being widely used for treating aortic stenosis. The company is focused on accelerating innovation in minimally invasive heart valve therapies. Medtronic offers a wide range of heart valve devices, including the Evolut™ R and Evolut™ PRO transcatheter aortic valve replacement (TAVR) systems, along with surgical heart valves and repair technologies.
Edwards Lifesciences Corporation
Edwards Lifesciences, headquartered in Irvine, California, specializes in artificial heart valves and hemodynamic monitoring. The company's portfolio includes transcatheter heart valves (THVs), including the SAPIEN™ series for aortic valve replacement. It also offers surgical heart valves and critical care monitoring devices, and significantly contributes to the United States heart valve devices market growth.
Abbott
Abbott, with its headquarters in Illinois (United States), has a prominent presence in the market. The company’s structural heart portfolio includes the MitraClip™ device for mitral valve repair, the TriClip™ device for tricuspid valve repair, and the Portico™ TAVR system for aortic valve replacement. Abbott engages in strategic acquisitions and product innovations to expand its footprint in the United States heart valve devices market.
Corcym Group
Corcym Group, a global medical device company specializing in the structural heart area, is one of the key players in the market. The company specializes in mechanical and biological heart valves, including the Carbomedics™ and Bicarbon™ series. While Corcym is based in Italy, its heart valve products are distributed in the United States through partnerships with local medical device companies.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Boston Scientific Corporation, Artivion, Inc., Shockwave Medical Inc. (Johnson & Johnson Services, Inc.), JenaValve Technology, Inc., and Micro Interventional Devices, Incorporated.
Key Questions Answered in the United States Heart Valve Devices Market Report
- What was the United States heart valve devices market value in 2025?
- What is the United States heart valve devices market forecast outlook for 2026-2035?
- What is the market segmentation based on valve type?
- What is the market segmentation based on product type?
- What is the market breakup based on the procedure?
- What is the market breakup by end user?
- What major factors aid the United States heart valve devices market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major drivers, opportunities, and restraints in the market?
- What are the major trends influencing the market?
- Who are the key players involved in the United States heart valve devices market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$1999 $1799
-
$3099 $2789
-
$4599 $3909
-
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Valve Type |
|
| Breakup by Product Type |
|
| Breakup by Procedure |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share